Clinical Trial Update: An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing plecanatide for efficacy and safety in adolescents (12 to <18) with chronic idiopathic constipation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• Plecanatide (plecanatide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Idiopathic Constipation | Phase 2 | Status: COMPLETED | Results posted: 2019-09-19